References
- Lacey J v, Chia VM, Rush BB, et al. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. Int J Cancer. 2012;131(8):1921–1929.
- Raffone A, Travaglino A, Saccone G, et al. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment. Gynecol Endocrinol. 2019;35(11):932–937.
- Li XC, Song WJ. Endometrial intraepithelial neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 world health organization classification for endometrial hyperplasia. Asian Pacific J Cancer Prev. 2013;14(10):5935–5939.
- Owings RA, Quick CM. Endometrial intraepithelial neoplasia. Arch Pathol Lab Med. 2014;138(4):484–491.
- Brémond A, Bataillard A, Thomas L, French National Federation of Cancer (FNCLCC), et al. Cancer of the endometrium. Br J Cancer. 2001;84(Suppl 2):31–36.
- Stevens EE, Yu S, van Sise M, et al. Hemoglobin A1c and the relationship to stage and grade of endometrial cancer. Arch Gynecol Obstet. 2012;286(6):1507–1512.
- Doherty MT, Sanni OB, Coleman HG, et al. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and Meta-analysis. PLoS One. 2020;15(4):e0232231.
- Wojciechowska J, Krajewski W, Bolanowski M, et al. Diabetes and cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes. 2016;124(5):263–275.
- Baak JP, Mutter GL, Robboy S, et al. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 world health organization classification system. Cancer. 2005;103(11):2304–2312.
- Yang YF, Liao YY, Peng NF, et al. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Pathol Res Pract. 2012;208(12):708–712.
- Poltavskiy E, Kim DJ, Bang H. Comparison of screening scores for diabetes and prediabetes. Diabetes Res Clin Pract. 2016;118:146–153.
- Lewin SN. Revised FIGO staging system for endometrial cancer. Clin Obstet Gynecol. 2011;54(2):215–218.
- Chen YL, Cheng WF, Lin MC, et al. Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia. J Formos Med Assoc. 2009;108(6):502–507.
- Folsom AR, Anderson KE, Sweeney C, et al. Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol. 2004;94(3):740–745.
- Levran D, Modan M, Menczer J, et al. Increased rate of glucose intolerance in endometrial cancer–a community-based study. Gynecol Obstet Invest. 1984;18(4):190–193.
- Travier N, Jeffreys M, Brewer N, et al. Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol. 2007;18(8):1414–1419.
- Matsuo K, Ramzan AA, Gualtieri MR, et al. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015;139(2):261–267.
- Raffone A, Travaglino A, Saccone G, et al. Diabetes mellitus Is associated with occult cancer in endometrial hyperplasia. Pathol Oncol Res. 2020;26(3):1377–1384.
- Vetter MH, Smith B, Benedict J, et al. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstetr Gynecol. 2020;222(1):60.e1–60.e7.
- Young Jeong J, Ook Hwang S, Lee BI, et al. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: a retrospective cohort study. PLoS One. 2020;15(12):e0243064.
- Giannella L, Carpini GD, Sopracordevole F, et al. Atypical endometrial hyperplasia and unexpected cancers at final histology: a study on endometrial sampling methods and risk factors. Diagnostics. 2020;10(7):474.
- Kurman Robert J, Norrıs Henry J. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Am Cancer Soc. 1982;49(12):2547–2559.
- Mitsuhashi A, Uehara T, Hanawa S, et al. Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer. Support Care Cancer. 2017;25(5):1495–1501.